Titlebook: Antiepileptic Drug Discovery; Novel Approaches Alan Talevi,Luisa Rocha Book 2016 Springer Science+Business Media New York 2016 Antiepilepto

只看該作者 · 發(fā)表于 2025-3-27 19:47:51

The Blood–Brain Barrier and the Design of New Antiepileptic Drugs

只看該作者 · 發(fā)表于 2025-3-27 23:01:16

只看該作者 · 發(fā)表于 2025-3-28 03:40:41

Synaptic Vesicle Protein 2A as a Novel Pharmacological Target with Broad Potential for New Antiepileof the role of SV2A in epilepsy, addressing three main issues: SV2A function in neurotransmission, the correlation of the expression and/or distribution of the protein with treatment response and neuronal damage, and the reasons that SV2A is a good molecular target for the discovery of new antiepile

只看該作者 · 發(fā)表于 2025-3-28 06:25:57

Glutamate Receptors as Targets for Novel Antiepileptic Drug Therapyharmacological blockade of glutamatergic signaling represents an attractive alternative for the control of seizures and neuroprotection. In particular, glutamate receptors are attractive targets for novel antiepileptic drugs because different studies have demonstrated that its agonists and antagonis

只看該作者 · 發(fā)表于 2025-3-28 12:33:33

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 16:55
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved